Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

NCT05647915 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

337

Enrollment

OTHER_GOV

Sponsor class

Conditions

Obesity
Obesity, Abdominal
NAFLD

Interventions

DRUG: Berberine plus lifestyle intervention
BEHAVIORAL: Placebo plus lifestyle intervention

Sponsor

China National Center for Cardiovascular Diseases